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osting by EAbstract Free radical formation in heme proteins is recognized as a factor in mediating the toxicity
of many drugs. Xenobiotics and drug therapy-related toxicity, due to oxidative modiﬁcation of
hemoglobin (Hb), has been attributed in part to the uncontrolled oxidative reactions. A variety
of antioxidant strategies to ameliorate potential oxidative damage in vivo have been suggested.
The present study was designed to evaluate the dose–response relationship of the free radical scav-
enging properties of silibinin dihemisuccinate (SDH) in nitrite-induced Hb oxidation in vitro and
in vivo. Different concentrations of SDH were added, before and after different intervals of inducing
Hb oxidation in erythrocytes lysate, and formation of methemoglobin (MetHb) was monitored
spectrophotometrically; the same approach was utilized to evaluate the effect of the same doses
of SDH on the integrity of erythrocytes after induction of hemolysis. Moreover, the most effective
dose of SDH was administered in rats before challenge with toxic dose of sodium nitrite, and
MetHb formation was monitored as mentioned before. The results showed that in both in vitro
and in vivo models, SDH successfully attenuates Hb oxidation after challenge with sodium nitrite;
this protective effect was not related to the stage of the catalytic stage of Hb oxidation, though the
effect was more prominent when the compound was administered before nitrite. In conclusion,901712624.
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178 B.H. Marouf et al.SDH can effectively, in concentration-dependent pattern, attenuate sodium nitrite-induced Hb oxi-
dation and maintain integrity of red blood cells both in vitro and in vivo.
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Increasing evidence suggests that free radical-induced oxida-
tive damages lead to various pathological events including
coronary heart disease, cancer and aging (Halliwell, 1996).
In particular, lipid peroxidation in biological membranes
has attracted much attention in relation to the deterioration
of membrane structure and impairment of enzymatic
functions (Mao and Poznansky, 1992; Koga et al., 1998).
Reactive oxygen species have been implicated in damages
of erythrocytes in patient with b-thalassemia, sickle cell ane-
mia, glucose-6-phosphate dehydrogenase deﬁciency and
other hemoglobinopathies (Hseu et al., 2002). The oxidation
of erythrocyte membranes serves as a model for the
oxidative damage of biomembranes (Einsele et al., 1985; Vis-
sers et al., 1994). The oxidation of erythrocyte and its ghost
membranes induced by free radicals have also been studied,
and it has been found that free radicals generated in the
aqueous phase attack the membrane to induce the chain
oxidations of lipids and proteins and eventually cause hemo-
lysis (Koga et al., 1998; Niki et al., 1988). Much interest
exists in the possibility that antioxidants reduce the risk of
degenerative diseases by inhibiting free radical induced oxi-
dative damage (Halliwell, 1996). Therefore, several studies
have examined both natural and synthetic antioxidants for
the inhibition of lipid peroxidation in membrane systems.
Flavonoids are naturally occurring substances that possess
various pharmacological actions and therapeutic applica-
tions. Some due to their phenolic structures have antioxidant
effect and inhibit free radical-mediated processes (Zhao,
2005; Mora et al., 1990). Silibinin, the major active ﬂavono-
lignan in the seeds of milk thistle (Silybum marianum) is iso-
lated from seeds. It is a free radical scavenger and a
membrane stabilizer that prevents lipoperoxidation and its
associated cell damage in some experimental models (Shalan
et al., 2005). Silibinin is used clinically to treat chronic
inﬂammatory liver disease and hepatic cirrhosis. Hepatopro-
tection can be attributed to its antioxidant properties by
scavenging free radicals and increasing intracellular concen-
tration of glutathione (DerMarderosian, 2001; Fleming,
2005). Silibinin received further attention due to its beneﬁ-
cial effects other than protection against tissue injury, effects
partly bound to its radical-scavenging properties. These in-
clude mostly anticancer and chemopreventive actions (Gallo
et al., 2003; Singh and Agarwal, 2006). Based on these
precedents, it can be inferred that blocking of free radical
propagation and lipid peroxidation would protect erythro-
cytes against the deleterious effect of oxidative stress due
to exposure to chemicals like nitrites. In the present study,
erythrocyte’s hemoglobin and plasma membrane were oxi-
dized by sodium nitrite and the protective effect of different
concentrations of silibinin dihemisuccinate on hemolysis and
methemoglobin formation was investigated.2. Experimental
2.1. Blood sample collection and preparation of lysate: in vitro
study
Blood samples were obtained from healthy individuals by vein-
puncture, and kept in ethylene diamine tetraacetic acid
(EDTA) containing tubes; then centrifuged at 2500 rpm and
4 C for 10 min to remove plasma and the buffy coat of white
cells. The erythrocytes were washed thrice with phosphate buf-
fer saline (PBS, pH 7.4) and lased by suspending in 20 volumes
of 20 mM phosphate buffer (PB, pH 7.4) to yield the required
hemolysate concentration of 1:20 (Doyle et al., 1982).
2.2. Preparation of silibinin dihemisuccinate sodium (SDHS)
solution
Different concentrations of silibinin dihemisuccinate sodium
(SDHS, Madaus, Germany) were prepared by dissolving the
required quantity in phosphate buffer (pH 7.4) to prepare
stock solution (103 mg/ml), from which serial dilutions were
made to give concentrations of 1015, 1012, 109 and 10
6 mg/ml.
2.3. Effect of different SDHS concentrations on the time course
of nitrite-induced oxidation of hemoglobin
In vitro model for oxidation of hemoglobin with sodium nitrite
was utilized for production of methemoglobin (MetHb). To
1.5 ml freshly prepared hemolysate, 1.0 ml of different concen-
trations of sodium SDHS (106, 109, 1012 and 1015 mg/ml)
were added each time concomitantly with 0.1 ml sodium nitrite
(Analar BDH Ltd., Poole, England) (ﬁnal concentration
6.0 mM), and the formation of MetHb was monitored spectro-
photometrically at 631 nm for 50 min using computerized UV–
visible spectrophotometer. Then to 1.5 ml freshly prepared
hemolysate, 1.0 ml of the highly effective concentration of
SDHS was added either 10 min before, or at 10 and 20 min
after the addition of sodium nitrite to the hemolysate solution,
and the formation of MetHb was monitored as previously
mentioned.
2.4. Effect of SDH on the nitrite-induced osmotic fragility of red
blood cells
Erythrocytes suspension was prepared by mixing a volume of
fresh blood with 20 volumes of phosphate buffered saline
(PBS, pH 7.4); aliquots (0.2 ml) of erythrocyte suspension
(2.5% hematocrit) were added to 1.8 ml of buffered saline solu-
tions of decreasing concentrations, pH 7.4 (NaCl concentration
range of 9.0–1.0 g/l). Different concentrations of sodium SDHS
(106, 109, 1012 and 1015 mg/ml) and 0.1 ml sodium nitrite
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cytes suspensions. The suspensions were allowed to stand for
30 min at room temperature, mixed again and then centrifuged
for 5 min at 1200 rpm. The supernatants were obtained and
the level of lysis was determined spectrophotometrically at
540 nm.The percentage of hemolysis was calculated from the ra-
tios of the absorbance (Dacie et al., 2001).
2.5. In vivo study: experimental animals and treatment schedule
Seven to eight-weeks old female Wistar Albino rats, weighing
160–280 g were purchased from the animal house of the College
of Pharmacy/Hawler Medical University. The animals were
housed in the animal house of the College of Pharmacy/Univer-
sity of Sulaimani in well ventilated plastic cages at 24 ± 2 C
and 50 ± 10 relative humidity, and subjected to 12 h light/
12 h dark cycle. They were acclimatized for 1 week before start-
ing the experiments, during which they had free access to stan-
dard commercial diet purchased from (Iraqi Center for Cancer
Research andMedical Genetics, Baghdad) and tapwater ad libi-
tum. After acclimatization of animals with the environment of
the animal house, they were randomly allocated into three
groups, each with six rats and treated as follows: ﬁrst group, po-
sitive control group; in which 1.0 ml of normal saline (0.9% so-
dium chloride) was given orally; 1 h later, sodium nitrite
(100 mg/kg) was given orally, after 45 min the animals were sac-
riﬁced by inhalation of high dose of anesthetic diethyl ether, and
intra-cardiac blood samples were taken for measurement of
MetHb level. Second and third groups: long- and short-term sil-
ibinin dihemisuccinate SDH (Tolbiac S.R., Argentina) expo-
sure; in the former, SDH (100 mg/kg) once daily was given
orally by gavage tube for 7 days; on the seventh day sodium ni-
trite (100 mg/kg) was given orally, 45 min later the animals were
sacriﬁced by inhalation of high dose of anesthetic diethyl ether,
and intra-cardiac blood samples were taken for measurement of
MetHb level. In the third group, SDH (100 mg/kg) was given as
a single oral dose; 1 h later, sodiumnitrite (100 mg/kg)was given
orally, after 45 min the animals were sacriﬁced by inhalation of
high dose of anesthetic diethyl ether, and intra-cardiac blood
samples were taken for measurement of MetHb level (Dacie
et al., 2001).
2.6. Statistical analysis
Data are expressed as the means ± SD. All the data were ana-
lyzed using Student’s test and Microsoft Excel software.
P< 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Effect of SDHS on the time-course of nitrite-induced
oxidation of Hb
Fig. 1 showed that SDHS, in concentration dependent pattern,
attenuates the rate of Hb oxidation and MetHb formation.
Linear relationship was reported between SDHS concentra-
tions and percent inhibition of MetHb formation (82.4%,
79.5%, 72% and 64.3%, respectively). The time required to
convert 50% of the available Hb to MetHb was 25 min in
the absence of SDHS (control), while it was delayed to 70,89.4, 122 and 150 min in the presence of 106, 109, 1012
and 1015 mg/ml SDHS, respectively (Table 1).
3.2. Effect of addition of SDHS at different time intervals
Addition of the highly effective concentration of SDHS
(106 mg/ml) to the hemolysate at different time intervals
(10 min before nitrite, 10 min and 20 min after nitrite addition,
i.e., during autocatalytic phase) produced remarkable decrease
in MetHb-related absorbance of light, attributed to signiﬁcant
inhibition of MetHb formation (83%, 77.4% and 75.3%,
respectively, Fig. 2). The time required to convert 50% of the
available Hb to MetHb was 25 min in the absence of SDHS
(control), and delayed to 146, 110 and 101 min when SDHS
(106 mg/ml) was added 10 min before nitrite, 10 min after
and 20 min after nitrite addition, respectively (Table 2).
3.3. Effect of different concentrations of SDHS on osmotic
fragility of red blood cells
The resistance of erythrocytes to lysis by diluted buffer saline
solutions of decreasing concentrations (NaCl range of 9.0–
1.0 g/l) was assayed. In Fig. 3 and 50% RBC hemolysis oc-
curred with 0.49% NaCl buffer saline solution when RBCs
were treated with sodium nitrite alone; whereas 0.47%,
0.45%, 0.43% and 0.36% buffer saline solution needed to
cause 50% lysis of RBCs when different concentrations of
SDHS (1015, 1012, 109 and 106 mg/ml, respectively) were
added to the incubation mixture in addition to sodium nitrite.
The ﬁgure shows the difference in susceptibility of human
RBCs to osmotic lysis when subjected to increasing hypotonic-
ity with and without addition of SDHS, which shift the curve
toward that of control RBCs which are not challenged by so-
dium nitrite.
3.4. Effect of SDH on nitrite-induced MetHb formation in rats
The results in Table 3 showed that MetHb% formed was sig-
niﬁcantly decreased (44.6%) in animals treated with SDH
(100 mg/kg orally) once daily for 7 days (long term silibinin
exposure) before induction of MetHb formation with orally
administered sodium nitrite (100 mg/kg), compared with saline
treated only animals (P< 0.05); whereas non-signiﬁcant dif-
ference was observed when SDH (100 mg/kg) administered
as single oral dose one hour before challenge with nitrite (short
term silibinin exposure) compared to control group.
4. Discussion
Sodium nitrite as a pro-oxidant induces a primary extensive
MetHb formation as a result of generation of several free rad-
ical species like superoxide anion, hydroxyl, peroxynitrite and
nitrogen oxide radicals which are implicated in promoting the
autocatalytic stage of oxidation of Hb by nitrite (Tesorierre
et al., 2001; Kumar et al., 2003); this reaction takes place with
a peculiar S-shaped proﬁle, and a noticeable increase in the
rate of the process after a clear lag time (Lissi, 1998). In the
present study, the formation of MetHb and the S-shaped curve
obtained during kinetic behavior of Hb oxidation may provide
an evidence for the formation of various free radicals during
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Figure 1 Effect of different concentrations of SDH (1015, 1012, 109 and 106 mg/ml) on the time-course of nitrite-induced oxidation
of hemoglobin in erythrocyte lysate.
Table 1 Effect of different concentrations of SDH (1015, 1012, 109 and 106 mg/ml) on the time-course of nitrite-induced
oxidation of hemoglobin.
Silibinin concentrations (mg/ml) % Formation of MetHb % Inhibition of MetHb Time to form 50% MetHb (t1/2) (min)
Control 100 0 25
Silibinin 1015 35.7 64.3 70
Silibinin 1012 28 72 89.4
Silibinin 109 20.5 79.5 121.9
Silibinin 106 17.6 82.4 150
Values represent mean of three experiments.
180 B.H. Marouf et al.the process of hemoglobin oxidation, which seems compatible
with previous ﬁndings reported by others (Lissi, 1998). Silibi-
nin, the naturally occurring ﬂavonolignan, acts mainly as an
effective antioxidant (Wellington and Adis, 2001) and displays
potential free radical scavenging property (Gharagozloo et al.,
2008). Although the pharmacology of silibinin has been exten-
sively studied, its molecular mechanisms of the antioxidative
activity have not been systematically investigated and remain
unclear (Gazak et al., 2009) and few studies have been devoted0
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Figure 2 Effect of addition of SDH (106 mg/ml) at different time in
time course of Hb oxidation erythrocyte lysate.to the identiﬁcation of silibinin active sites (Gyorgy et al.,
1992). In the present study, the ability of different concentra-
tions of SDHS to scavenge various types of free radicals was
evaluated, and concentration–effect relationship was reported
in the in vitro model of Hb oxidation in hemolysate. In accor-
dance with the previous ﬁndings, several free radical species
are generated during the course of nitrite-induced oxidation
of Hb (Kumar et al., 2003). The present study has shown that
SDHS can protect hemoglobin against oxidation by sodium ni-25 30 35 40 45 50
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tervals (10 min before, 10 and 20 min after nitrite addition) on the
Table 2 Effect of addition of SDH (106 mg/ml) at different time intervals (10 min before, 10 and 20 min after nitrite) on the time
course of Hb oxidation in erythrocyte lysate.
Time-course for addition of
106 mg/ml silibinin
% Formation of
MetHb
% Inhibition of
MetHb
Time to form 50% MetHb
(t1/2) (min)
Control 100 0 25
Incubation before 10 min 17 83 146
Addition after 10 min 22.6 77.4 110
Addition after 20 min 24.7 75.3 101
Values represent mean of three experiments.
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Figure 3 Effects of different concentrations of SDH on the osmotic fragility of red blood cells challenged with sodium nitrite in vitro.
Table 3 Effects of single and multiple doses of SDH (100 mg/
kg) on nitrite-induced MetHb formation in rats.
Type of treatment n % MetHb formation
Saline treated only 6 55.6 ± 6.0
Pre-treatment with SDH for 7 days 6 30.8 ± 13.6*,a
Treatment with single dose SDH 6 55.9 ± 9.3b
Each value represents mean ± SD; n= number of animals.
Values with non-identical superscripts (a and b) were considered
signiﬁcantly different (P< 0.05).
* Signiﬁcantly different compared to saline treated group
(P< 0.05).
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ﬂavonoids has been studied in details (Choi et al., 2002); how-
ever, only few data are known regarding SAR of ﬂavonolign-
ans. On the basis of these studies, the major determinants
important for a high radical-scavenging capability were sug-
gested, including the presence of catechol or pyrogallol group
in ring B and the 3-OH group connected to a 2,3 double bond
conjugated with the C-4 carbonyl group in the dehydrosilybin,
a metabolite of silibinin (Gazak et al., 2009). Another factor
which increases the potency of ﬂavonoid to interact with rad-
icals is the presence of a galloyl group in the molecule (Choi
et al., 2002). Preventing the onset of the autocatalytic stage
of nitrite-induced oxidation of Hb after addition of silibininsuggests that such protective effect might be due to its radical
scavenging activity and not due to reduction of MetHb to Hb,
because it fails to reverse the oxidized hemoglobin (i.e., the
formed MetHb) after 10 and 20 min of addition of nitrite.
Additionally, direct interaction between nitrite and silibinin,
as a reason for protection, can be ruled out because the con-
centration of silibinin which protects the Hb is very low.
SDH proved to be a powerful scavenger of OH through differ-
ent mechanisms, including addition reaction on the aromatic
rings, abstraction of phenolic hydrogen and decarboxylation
reaction (Khlebnikov et al., 2007). Furthermore, recent studies
suggest that structural requirement for hydroxyl radical scav-
enging include the presence of the hydroxyl group in ring C,
and probably 30-methoxy-40-hydroxylphenyl group in ring D.
In spite of directly scavenging radicals (superoxide, hydrogen
peroxide, nitric oxide and hydroxyl radicals) (Thomasset
et al., 2007), the antioxidant effect of ﬂavonoids may result
from the interaction between ﬂavonoids and metal ions, espe-
cially iron and copper, leading to chelate formation. It is be-
lieved that both iron chelation and free radical scavenging
activities accounts for the antioxidative ability for ﬂavonoids
(Mira et al., 2002). However, few studies have investigated
the molecular basis for these effects, where the polyphenol
structure allows both the scavenging of free radicals, with con-
comitant formation of fairy stable aroxyl radicals, and chela-
tion of transition metals including iron (El-Hajji et al., 2006).
Silibinin, in addition to its antioxidant and free radical scav-
enging abilities, has the ability to act as iron chelator (Borsari
182 B.H. Marouf et al.et al., 2001); it possesses a hydroxyl group at C5 and C3 in
addition to the carbonyl group at C4 and two carboxylate
groups which may form chelates with divalent cation (Mora
et al., 1990); the fact that hemoglobin Fe(II) can serve as a
Fenton reagent catalyzing the conversion of H2O2 to OH

and OH, and as long as O2 is available to reduce the oxidized
Fe(III), the catalytic cycle can continue to generate hydroxyl
radicals (Kiefer and Snyder, 2000). Although the present study
did not investigate the effect of silibinin as iron chelator, but
utilizing hemoglobin oxidation system as a model cannot ex-
clude this effect of silibinin. The protective effect of silibinin
on hemolysate was found to be compatible with the reported
protective effect of silymarin on erythrocyte hemolysate
against benzo(a)pyren and exogenous reactive oxygen species
(Kiruthiga et al., 2007). Oxidation of erythrocyte membrane
induced by free radicals, which are generated in the aqueous
phase, attack the membrane to induce a peroxidation of the
unsaturated fatty acids and phospholipids that lead to hemoly-
sis (Bensoltane et al., 2006). In the present study, erythrocytes
were oxidized by sodium nitrite and the protective effect of sil-
ibinin on RBC hemolysis was investigated. Nitrite has a strong
oxidant effect on RBC membrane and its hemoglobin; during
the course of this reaction, reactive oxygen radicals are pro-
duced and start to induce a peroxidation of the unsaturated
fatty acids of the phospholipid structure of the plasma mem-
brane. Thus it appears like an osmotic brittleness of the eryth-
rocyte membrane as well as a disturbance of membrane
transport which leads to hemolysis (Bensoltane et al., 2006).
The oxidative damage to hemoglobin molecule caused by in-
haled nitrite can induce the dissociation of heme and globin
chains, consequently forming polymerized globin aggregates
known as Heinz bodies. These aggregates are attached to the
membrane of the red blood cell, thereby altering its shape
(Neuberger et al., 2002). Additionally hyper-polarization of
erythrocyte membranes and an increase in membrane rigidity
have been observed as a result of RBC oxidation by sodium
nitrite. The interaction of nitrite with cell membrane also dras-
tically modiﬁed the erythrocyte membrane (Zavodnik et al.,
1999), and nitrite-induced methemoglobinemia in RBC lead
to an inhibition of red blood cell sodium/proton exchanger;
the membrane potential changes after exposure of RBCs to ni-
trite which reﬂects the alteration of the activity of membrane
ionic exchangers. The decrease in membrane ﬂuidity may re-
sult from the changes in the membrane structural state due
to the oxidative process within the membrane provoking
hemolysis (Batina et al., 1990). The present study shows that
SDHS protects human erythrocytes against nitrite-induced
oxidative hemolysis in concentration-dependent manner. Free
radicals attack erythrocyte membrane components such as
proteins and lipids, and change the structure and function of
this membrane which may result in hemolysis (Vissers et al.,
1994). Various studies indicated that silibinin signiﬁcantly in-
creases glutathione levels, which serve as a free radical scaven-
ger (Das and Vasudevan, 2006). Silibinin is relatively
hydrophobic and its penetration into the cell is limited
(Sainz-Pardo et al., 1994) and membrane structures are postu-
lated to be one of the cellular targets for silibinin as it interacts
with the surface of lipid bilayer (Wesolowska et al., 2007), its ef-
fect on erythrocytes may be explained by their incorporation
into these lipid bilayers of the cell membrane leading to reducing
hemolysis. Silibinin on the other hand, is able to increase the
activity of both superoxide dismutase and glutathione peroxi-dase, which may explain the protective effect of the drug against
free radicals and also stabilizing the effect on the red cell mem-
brane (Altorjay et al., 1992). The possibility that silibinin exerts
its cytoprotective effects at themembrane level, as a chain break-
ing antioxidant, should also be considered. In fact, Miki and
Mino (1985) established that hemolysis happenswhen the eryth-
rocyte membrane alpha tocopherol concentration has lowered
to a critically low level; therefore silibinin may interact with lip-
operoxyl radicals and spare alpha tocopherol molecules (Miki
and Mino, 1985). In conclusion, silibinin dihemisuccinate pro-
tects hemoglobin and erythrocyte plasma membrane against
the oxidative damage induced by sodium nitrite, which may be
attributed to direct radical scavenging properties.Acknowledgments
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